Phase 4 N=125 Quality of Life Intermittent Catheter Study
Neurogenic Bladder Dysfunction Nos
Primary: Quality of Life (0-100 Point) — 76.8; 59.8 units on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=451 Persons With Disabilities Generating Quality Metrics
Physical Disability · Chronic Mental Disorder
Primary: Improved Quality of Care — 45; 68; 53 Participants — p=0.074
N/A N=36 Outlook Quality of Life Intervention
Cancer · Congestive Heart Failure · Chronic Obstructive Pulmonary Disease
Primary: Quality of Life - Preparation — 14.4; 16.0; 15.4; 15.2 units on a scale — p=.047
N/A N=221 Outlook Quality of Life Intervention Study
Cancer · Congestive Heart Failure (CHF) · Chronic Obstructive Pulmonary Disease (COPD)
Primary: QUAL-E - Preparation Sub-scale — 15.7; 14.5; 14.8; 16.0 units on a scale — p=<0.61
N/A N=161 How Has Glaucoma Affected Your Quality of Life?
Glaucoma · Quality of Life
Primary: Quality of Life With NEI VFQ-25 — 82.9; 82.7; 82.8; 83.0 units on a scale
Phase 4 N=482 Evaluation of Quality of Life (QoL) in Subjects With Highly Active Relapsing Multiple Sclerosis (MS) (CLARIFY MS)
Multiple Sclerosis
Primary: Change From Baseline in Multiple Sclerosis Quality of Life-54 Questionnaire (MSQoL-54) Physical Health Composite Summary and Mental Health Composite Summary Scores at…
N/A N=1,075 Quality of Life and Depression in Dialysis Patients
Chronic Kidney Disease Stage 5
Primary: Change of Kidney Disease Quality of Life Short Form 1.3 (KDQOL SF 1.3) Score and Beck Depression Inventory(BDI) Score From Visit 1 Period — 1.22; -1.50; 1.62; 0.46 units…
N/A N=76 Pediatric Quality of Life Among Population With Body Mass Index (BMI) Greater Than or Equal to 85%
Pediatric Obesity
Primary: Change in Child Self-report Health Related Quality of Life Scores After Intervention: Total, Physical and Psychosocial (Presented in This Order) — 7.8; -0.9; 9.1; -0.3…
N/A N=603 Quality Of Life Assessment In Alzheimer's Disease (AD) Patients Receiving Aricept Tablets
Alzheimer Disease
Primary: Number of Participants for Change From Baseline for Clinical Global Impressions of Improvement (CGI-I) at Week 12 — 26; 5; 27; 103 participants — p=0.0023
N/A N=130 Quality of Life During Treatment of Chronic Hepatitis C (P05278/MK-4031-336)
Hepatitis C, Chronic · Genotype 1 · HCV-1
Primary: Change From Baseline (BL) to Week 72 (WK72) in 36-Item Short-Form Health Survey (SF-36) Scores — 87.27; 87.33; -1.56; 81.71 score on a scale
N/A N=72 Disability and Quality of Life in Patients With Lymphatic Filariasis in Rural Southern India
Lymphatic Filariasis
Primary: Dermatology Life Quality Index (DLQI) Domain Scores — 3; 0; 1; 0 units on a scale
N/A N=101 Quality of Life After Interventional Thyroid Treatment
Thyroid; Deficiency · Quality of Life
Primary: ThyPRO Scale Scores (0-100, Higher Scores Indicating Worse Quality of Life) — 18.3; 19.9 score — p=<0.001
N/A N=126 Acromegaly Treatment Quality of Life Study
Acromegaly
Primary: Acromegaly Quality of Life (ACROQoL) Global Score — 57; 60; 54 points on a scale
N/A N=154 Home Away From Home - Quality of Life Surveys
Pediatric Acute Myeloid Leukemia
Primary: Compare Differences in HRQOL Scores Between Outpatient Versus Inpatient Management — 70.1; 68.7 score on a scale
N/A N=50 HRQoL in the Low MELD Pre-tx Population
Cirrhosis of the Liver
Primary: Perceived HRQoL Score. Overall Qualty of Life Index Tool Was Utilized. — 20.19 scores on a scale
Phase 4 N=116 Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma
Asthma
Primary: The Mean Change From Baseline to Week 20 in the Overall Asthma Quality of Life Questionnaire (AQLQ) — 3.1; 3.1; 4.4; 3.0 Units on a scale
Phase 2 N=146 Quality of Life in Locally Advanced or Metastatic Pancreatic Cancer Treated With Gemcitabine and Nab-paclitaxel
Pancreatic Cancer
Primary: Deterioration-free Survival Rate of the QOL Global Health Status at 3, 6 and 12 Months (Mos) — 89; 73; 74; 59 percentage of participants
N/A N=153 Quality of Life and Psychosocial Factors Associated With Severe Psoriasis Following Treatment With Adalimumab
Psoriasis
Primary: Dermatology Life Quality Index (DLQI) Scores — 17.25; 8.65; 4.51; 3.65 units on a scale
N/A N=10 Effect of a Dietary Supplement on Quality of Life
Quality of Life
Primary: Chubon Lifestyle Score — 103.9; 100.9; 100.4; 102.9 score on a scale
Phase 2 N=131 Evaluation of the Quality of Life Questionnaire-Bronchiectasis (QOL-B) in Patients With Bronchiectasis
Bronchiectasis
Primary: Reliability of the Respiratory Domain of the Quality of Life Questionnaire-Bronchiectasis (QOL-B) — 0.80 Intraclass Correlation Coefficient
N/A N=39 Quality of Life Impact of Nasal Airway Treatment With Aerin Medical Device
Nasal Obstruction
Primary: Change From Baseline NOSE Score — 53.3; 48.1; 53.5 units on a scale — p=<0.0001
N/A N=27 Does Using a Low Vision Aid Device Improve Quality of Life in Glaucoma Patients?
Glaucoma
Primary: Impact of OrCam on Vision-related Quality of Life — 20 Participants
N/A N=59 Patient- and Caregiver-reported Symptoms and Outcomes With Levodopa/Carbidopa Intestinal Gel for the Treatment of Advanced Parkinson's Disease
Parkinson's Disease
Primary: Change From Baseline in Parkinson's Disease Questionnaire-39 Item (PDQ-39) Global Score at Month 6 — -12.81 units on a scale — p=< 0.0001
N/A N=37 Prospective Evaluation of the Impact on Patients' Quality of Life of a 12-Week Adapted Physical Activity Program (APA)
Sports Physical Therapy
Primary: Quality of Life of Patients Participating in the 12-week Adapted Physical Activity Program. — 117.6 score on a scale
Phase 4 N=901 Open-Label Study to Assess the Effect of Long-Term Prolonged-Release Fampridine (BIIB041) on Quality of Life as Reported by Participants With Multiple Sclerosis
Multiple Sclerosis
Primary: Change From Baseline in the Physical Component Scale (PCS) of the Short Form 36 Health Status Questionnaire (SF-36) At Months 3, 6, 9, and 12: Responders — 4.2; 3.4…
Phase 4 N=299 A Study Evaluating Quality of Life Parameters Following Use of Emergen-C
Dietary Supplements
Primary: Adjusted Mean Change From Baseline in Multidimensional Fatigue Inventory (MFI) General Fatigue Domain Score at Week 12 — -5.23; -5.48 score on a scale — p=0.5472
N/A N=38 Improving Quality of Life for Veterans With Stroke and Psychological Distress
Stroke · Depression · Anxiety
Primary: Stroke Specific Quality of Life Scale Change — 41.24; 41.67 units on a scale
Phase 3 N=232 Rebif New Formulation (RNF) Quality of Life (QOL) Study
Relapsing Multiple Sclerosis
Primary: Percent Change in Global Side Effects (GSE) on Multiple Sclerosis Treatment Concerns Quesionnaire (MSTCQ) — 5.0 percent change — p=<0.001
N/A N=350 Evaluation of Outcomes for Quality of Life and Activities of Daily Living for BKP in the Treatment of VCFs
Compression Fracture of Vertebral Body · Osteoporosis · Cancer
Primary: Back Pain Change From Baseline at 3 Months — 8.7; 2.7; -6.0 units on a scale
N/A N=500 Greek Study of the Quality of Life in Patients With Psoriasis Treated With Adalimumab
Psoriasis
Primary: Mean Change of Dermatology Life Quality Index (DLQI) Scores — 4.9; 9.3; 11.3; 12.1 units on a scale